Professor Marshall, the Nobel Prize winner, pointed out in his speech on "Nobel Prize and Probiotics": The development of probiotic biotechnology can effectively solve the problem of recurring gastrointestinal diseases. This area has reached the forefront of the industry. This scientific and technological achievement is being widely used to solve gastrointestinal problems. Industry predictions: With the reasonable and effective use of super probiotics, humans will eventually defeat gastrointestinal problems.
Efficacy of probiotics
The simultaneous use of multiple live bacteria has significant effects
The super probiotics jointly developed by scientists from China and Russia solve the traditional problem of There are two major medical problems in live bacterial preparations: "single strain" and "production process". The combination of various beneficial bacteria used in conjunction with Vilexu probiotics makes it difficult for gastrointestinal patients to relapse after recovery, and the efficiency of gastrointestinal diseases is greatly improved.
The application of probiotics in Helicobacter pylori infection
Nobel laureate Professor Marshall, when attending the first global live bacteria exhibition, especially praised the multi-strain combined probiotics for their Five unparalleled effects of traditional medicine:
1. The combined use of multiple bacteria is 28 times more effective than using one type of bacteria. It is resistant to oxygen and acid, and can survive in gastric acid and intestinal mucus environments. Reproduction and technology have surpassed Europe and the United States.
2. The content of beneficial bacteria contained in super probiotics exceeds 10 billion per gram. Due to the high content of live bacteria, the average patient can effectively relieve stomach distension and pain after taking it for only 15 minutes.
The addition of probiotics can help improve the eradication rate of Helicobacter pylori
3. The combined use of multiple flora can improve gastrointestinal immunity, prevent recurrence after recovery, and prevent atrophic Gastritis and malignant transformation of ulcerative colitis. In speaking engagements around the world, Marshall asserts that “using multi-microbiota technologies like probiotics, the medical community will be able to treat gastroenteritis more easily than the cold.”
4. Treat bacteria with bacteria and treat gastrointestinal disease at the same time. It can activate beneficial bacteria and digestive enzymes, kill harmful bacteria, and directly supplement tens of billions of super probiotics to comprehensively target the source of gastrointestinal diseases, restore gastrointestinal function, and treat gastrointestinal tract.
5. Improve immunity and prevent recurrence. It can form a biological protective film on the inner wall of the gastrointestinal tract, blocking the erosion of the gastrointestinal mucosa by harmful bacteria, while improving immunity, improving physical fitness, and making it less likely to relapse.